Immunological and hormonal effects of exercise: Implications for cancer cachexia

Current Opinion in Supportive and Palliative Care

Volumn 7, Issue 4, 2013, Pages 376-382

  Maddocks, Matthew ^a   Jones, Lee W ^b   Wilcock, Andrew ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b DUKE CANCER INSTITUTE   (United States)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Cachexia; Cancer; Exercise; Hormonal; Immune system

Indexed keywords

HORMONE;

CACHEXIA; EXERCISE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; KINESIOTHERAPY; METABOLISM; METHODOLOGY; NEOPLASM; PHYSIOLOGY; REVIEW;

CACHEXIA; EXERCISE; EXERCISE THERAPY; HORMONES; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NEOPLASMS;

EID: 84887874222     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0000000000000010     Document Type: Review

References (58)

1. Gould DW, Lahart I, Carmichael AR, et al. Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 2013; 4:111-124.
2. Argilés JM, Busquets S, López-Soriano FJ, et al. Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 2012; 3:73-76.
3. Maddocks M, Murton AJ, Wilcock A. Therapeutic exercise in cancer cachexia. Crit Rev Oncog 2012; 17:285-292.
4. Maddocks M, Murton AJ, Wilcock A. Improving muscle mass and function in cachexia: nondrug approaches. Curr Opin Support Palliat Care 2011; 5:361-364.
5. Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncologica 2013; 52:195-215.
6. Betof AS, Dewhirst MW, Jones LW. Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. Brain Behav Immun 2013; 30:S75-S87.
7. Pierce BL, Neuhouser ML, Wener MH, et al. Correlates of circulating Creactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Tr 2009; 114:155-167.
8. Galvao DA, Taaffe DR, Spry N, et al. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010; 28:340-347.
9. Lee DH, Kim JY, Lee MK, et al. Effects of a 12-week home-based exercise program on the level of physical activity, insulin, and cytokines in colorectal cancer survivors: a pilot study. Support Care Cancer 2013; 21:2537-2545.
10. Hwang CL, Yu CJ, Shih JY, et al. Effects of exercise training on exercise capacity in patients with nonsmall cell lung cancer receiving targeted therapy. Support Care Cancer 2012; 20:3169-3177.
11. Gómez Am, Martinez C, Fiuza-Luces C, et al. Exercise training and cytokines in breast cancer survivors. Int J Sports Med 2011; 32:461-467.
12. Payne JK, Held J, Thorpe J, et al. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 2008; 35:635-642.
13. Janelsins MC, Davis PG, Wideman L, et al. Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer 2011; 11:161-170.
14. Fairey AS, Courneya KS, Field LJ, et al. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003; 12:721-727.
15. Allgayer H, Nicolaus S, Schreiber S. Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment. Cancer Detect Prev 2004; 28:208-213.
16. Ligibel JA, Campbell N, Partridge A, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008; 26:907-912.
17. Irwin ML, Varma K, Alvarez-Reeves M, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev 2009; 18:306-313.
18. Irwin ML, Smith AW, McTiernan A, et al. Influence of pre and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 2008; 26:3958-3964.
19. Schmitz KH, Ahmed RL, Hannan PJ, et al. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev 2005; 14:1672-1680.
20. Segal RJ, Reid RD, Courneya KS, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009; 27:344-351.
21. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003; 21:1653-1659.
22. Jones LW, Liang Y, Pituskin EN, et al. Effect of exercise training on peak oxygen consumption in patients with cancer: a meta-analysis. Oncologist 2011; 16:112-120.
23. Speck RM, Courneya KS, Masse LC, et al. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010; 4:87-100.
24. Lakoski SG, Eves ND, Douglas PS, et al. Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol 2012; 9:288-296.
25. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12:489-495.
26. Laviano A, Meguid MM, Inui A, et al. Therapy insight: Cancer anorexiacachexia syndrome-when all you can eat is yourself. Nat Clin Pract Oncol 2005; 2:158-165.
27. Weber MA, Krakowski-Roosen H, Schroder L, et al. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia. Acta Oncol 2009; 48:116-124.
28. Stephens NA, Gray C, MacDonald AJ, et al. Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr 2012; 31:499-505.
29. England R, Maddocks M, Manderson C, et al. Factors influencing exercise performance in thoracic cancer. Respir Med 2012; 106:294-299.
30. Jones LW, Hornsby WE, Goetzinger A, et al. Prognostic significance of functional capacity and exercise behavior in patients with metastatic nonsmall cell lung cancer. Lung Cancer 2012; 76:248-252.
31. Wilcock A, Maddocks M, Lewis M, et al. Symptoms limiting activity in cancer patients with breathlessness on exertion: ask about muscle fatigue. Thorax 2008; 63:91-92.
32. Dodson S, Baracos VE, Jatoi A, et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2011; 62:265-279.
33. Prado CM, Baracos VE, McCargar LJ, et al. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 2007; 13:3264-3268.
34. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009; 15:2920-2926.
35. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9:629-635.
36. Antoun S, Lanoy E, Iacovelli R, et al. Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies. Cancer 2013; 25:28218.
37. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31:1539-1547.
38. Fearon KCH, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signalling and metabolic pathways. Cell Metab 2012; 16:153-166.
39. Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev 2009; 89:381-410.
40. Molfino A, Laviano A, Rossi Fanelli F. Contribution of anorexia to tissue wasting in cachexia. Curr Opin Support Palliat Care 2010; 4:249-253.
41. Wilcock A. Cachexia and omega-3 polyunsaturated fatty acids: the beginning of the end or the end of the beginning? Palliat Med 2005; 19:500-502.
42. Melstrom LG, Melstrom KA, Ding XZ, Adrian TE. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 2007; 22:805-814.
43. McCall JL, Tuckey JA, Parry BR. Serum tumour necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 1992; 79:1361-1363.
44. Sishi BJ, Engelbrecht AM. Tumor necrosis factor alpha (TNF-a) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes. Cytokine 2011; 54:173-184.
45. Johns N, Stephens NA, Fearon KC. Muscle wasting in cancer. Int J Biochem Cell Biol 2013; 45:2215-2219.
46. Skipworth RJ, Moses AG, Sangster K, et al. Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer. Support Care Cancer 2011; 19:391-401.
47. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98:1154-1162.
48. Nieman DC. Clinical implications of exercise immunology. J Sport Health Sci 2012; 1:12-17.
49. McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev 2013; 39:534-540.
50. Moses AG, Maingay J, Sangster K, et al. Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 2009; 21:1091-1095.
51. Proctor MJ, Morrison DS, Talwar D, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 2011; 104:726-734.
52. Gleeson M, Bishop NC, Stensel DJ, et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011; 11:607-615.
53. Pedersen BK, Hoffman-Goetz L. Exercise and the immune system: regulation, integration and adaptation. Physiol Rev 2000; 80:1055-1081.
54. Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med 2005; 35:339-361.
55. Berzosa C, Criswell D, Lawler JM, et al. Acute exercise increases plasma total antioxidant status and antioxidant enzyme activities I untrained men. J Biomed Biotechnol 2011; 2011:540458.
56. Marimuthu K, Murton AJ, Greenhaff PL. Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. J Appl Physiol 2011; 110:555-560.
57. Oldervoll LM, Loge JH, Lydersen S, et al. Physical exercise for cancer patients with advanced disease: a randomized controlled trial. Oncologist 2011; 16:1649-1657.
58. Cheville AL, Kollasch J, Vandenberg J, et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage 2013; 45:811-821.